Ken Katoh

Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue

Ken Katoh, Kenji Mizuno, Shigeatsu Hashimoto et al. · Life Sciences · 1994 · 27 citations

Inflammation, Vascular Disease, Vascular Adaptation +9

Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus

Ken Katoh · Diabetes Research and Clinical Practice · 1992 · 22 citations

Metabolic Syndrome, Cardiovascular Disease, Non-hyperlipidemic Type 2 +14

A Patient With Preclinical Cushing's Syndrome and Excessive DHEA-S Secretion Having Unilateral Adrenal Carcinoma and Contralateral Adenoma.

Sanae Midorikawa, SHICEATSU HASHIMOTO, Minoru Kuriki et al. · Endocrine Journal · 1999 · 20 citations · Full text

TCV−116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats

Kenji Mizuno, Susumu Niimura, Ken Katoh et al. · Life Sciences · 1994 · 20 citations

Hypertension, Cardiovascular Disease, Medicine +11